---
title: Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive
  relapsed and refractory multiple myeloma
date: '2024-06-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38898589/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240620182206&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Pomalidomide-PACE was able to induce rapid responses in
  heavily pretreated, aggressive RRMM with a manageable toxicity profile and therefore
  offers an effective salvage regimen and a potential bridging strategy to further
  treatment options such as chimeric antigen receptor T-cell ...'
disable_comments: true
---
CONCLUSION: Pomalidomide-PACE was able to induce rapid responses in heavily pretreated, aggressive RRMM with a manageable toxicity profile and therefore offers an effective salvage regimen and a potential bridging strategy to further treatment options such as chimeric antigen receptor T-cell ...